IMATINIB Devatis cpr pell 200 mg 30 pce

7680655800090 CH-65580 L01XE01 07.16.1.

Reimbursement limitations:

GLIVEC

Traitement des patients adultes et pédiatriques atteints de leucémie myéloïde chronique Ph+ (LMC Ph+) en …

IMATINIB Devatis cpr pell 200 mg 30 pce
IMATINIB Devatis cpr pell 200 mg 30 pce
IMATINIB Devatis cpr pell 200 mg 30 pce
1 / 3
google

Details

Product number
6558002
CPT
-
Packaging group
30
Unit
Tablette(n)
Composition
imatinibum 200 mg ut imatinibi mesilas, cellulosum microcristallinum, hypromellosum, crospovidonum, silica colloidalis anhydrica, magnesii stearas, Überzug: poly(alcohol vinylicus), macrogolum, E 172 (flavum), talcum, E 172 (rubrum), E 171, pro compresso obducto.

Articles (1)

Imatinib Devatis 200 mg, Filmtabletten
Filmtabletten
30
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
21/06/2022
Patient information leaflet
Français
21/06/2022
Patient information leaflet
Italien
21/06/2022
Professional SmPC
Allemand
21/06/2022
Professional SmPC
Français
21/06/2022
Professional SmPC
Italien
21/06/2022

Detailed composition

Substance Quantity Type Category
(N/A)
200.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance FNIDK

Reimbursement information

Public price
CHF 484.65
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/06/2019

Authorization holder

Devatis AG

6330 Cham

Authorization information

Swissmedic authorization number
65580
Drug name
Imatinib Devatis, Filmtabletten
Galenic form
FILM
ATC Code
L01XE01
Authorization status
Z
Dispensation category
A
First authorization
09/10/2015
Authorization expiration date
31/12/9999
IT number
07.16.1.
Domain
Human medicine
Field of application
Zytostatikum Ph+ chronische myeloische Leukämie (Ph+CML) Ph+ akute lymphatische Leukämie (Ph+ALL) Hypereosinophilensyndrom (HES/CEL) Atypische myelodysplastische/myeloproliferative Erkrankungen (MDS/MPD) Aggressive systemische Mastozytose (aggr. SM) Gastrointestinale Stromatumoren (GIST) Dermatofibrosarkom protuberans (DFSP) (für genaue Angaben zur Indikation siehe aktuelle Fachinformation

Packaging details

Description (FR)
IMATINIB Devatis cpr pell 200 mg 30 pce
Description (DE)
IMATINIB Devatis Filmtabl 200 mg 30 Stk
Market launch
09/10/2015
Narcotic (BTM)
No

Other packaging sizes

IMATINIB Devatis cpr pell 100 mg 30 pce
30 TABL
View
IMATINIB Devatis cpr pell 100 mg 60 pce
60 TABL
View
IMATINIB Devatis cpr pell 200 mg 60 pce
60 TABL
View
IMATINIB Devatis cpr pell 400 mg 30 pce
30 TABL
View